Richard H. Ko

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

Richard H. Ko, Lingyun Ji, Phillip Barnette et al. · Journal of Clinical Oncology · 2009 · 273 citations · Full text

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Matthew F. Gorman, Lingyun Ji, Richard H. Ko et al. · Pediatric Blood & Cancer · 2010 · 111 citations

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Rebecca Kruse‐Jarres, Michael U. Callaghan, Stacy E. Croteau et al. · Blood · 2017 · 50 citations

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies

Rebecca Kruse‐Jarres, Flora Peyvandi, Johannes Oldenburg et al. · Blood Advances · 2022 · 43 citations · Full text

A computer‐based model to assess costs associated with the use of factor VIII and factor IX one‐stage and chromogenic activity assays

Steve Kitchen, James Blakemore, Kenneth D. Friedman et al. · Journal of Thrombosis and Haemostasis · 2016 · 36 citations · Full text